# A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients

> **NCT01014442** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 68 (actual)

## Conditions studied

- Lung Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01014442
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014442, "A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01014442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*